Table 1.
Characteristics of Sample Patients (n = 396)
| |
Descriptive statistics |
Comparative analysis |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sociodemographic variables | Total sample n = 396 | Older Aged (≥65) n = 126 | Middle-aged (45–64) n = 214 | Younger aged (20–44) n = 56 | t or χ2 | DF | p-value | ||||
| Age, M (SD) | 58.6 | (12.5) | 72.4 | (5.7) | 55.8 | (5.7) | 38.1 | (6.1) | |||
| Education, M (SD) | 12.6 | (4.0) | 12.3 | (5.1) | 12.9 | (3.3) | 12.5 | (3.6) | 0.9 | 2 | 0.41* |
| Karnofsky, M (SD) | 64.9 | (16.1) | 61.9 | (16.0)a | 66.9 | (15.6)a | 64.0 | (17.5) | 3.8 | 2 | 0.02 |
| CC M (SD) | 8.3 | (2.7) | 10.0 | (2.7)ac | 8.0 | (2.1)ab | 5.9 | (1.9)bc | 65.7 | 2 | <0.001† |
| Male, n (%) | 221 | (55.8) | 75 | (59.5) | 118 | (55.1) | 28 | (50.1) | 1.5 | 2 | 0.47 |
| Health Insurance, n (%) | 239 | (61.9) | 95 | (77.9)ac | 116 | (55.8)a | 28 | (50.0)c | 19.9 | 2 | <0.001 |
| Medicare, n (%) | 170 | (43.9) | 102 | (84.3)ac | 48 | (22.8)a | 20 | (36.4)c | 119.8 | 2 | <0.001 |
| Married, n (%) | 244 | (62.4) | 75 | (61.0) | 134 | (63.2) | 35 | (62.5) | 0.2 | 2 | 0.92 |
| Race, n (%) | 25.0 | 8 | 0.002 | ||||||||
| White | 260 | (65.7) | 92 | (73.0)c | 144 | (67.3)b | 24 | (42.9)cb | 16.2 | 2 | <0.001 |
| Hispanic | 58 | (14.7) | 18 | (14.3)c | 23 | (10.8)b | 17 | (30.4)cb | 13.7 | 2 | 0.001 |
| Black | 7 | (17.9) | 14 | (11.1) | 44 | (20.6) | 13 | (23.2) | 6.1 | 2 | 0.05 |
| Asian | 5 | (1.3) | 2 | (1.6) | 2 | (0.9) | 1 | (1.8) | 0.4 | 2 | 0.81 |
| Other | 2 | (0.5) | 0 | (0.0) | 1 | (0.7) | 1 | (4.0) | 4.2 | 2 | 0.13 |
| Religion, n (%) | 20.8 | 14 | 0.11 | ||||||||
| Catholic | 145 | (36.6) | 50 | (39.7) | 74 | (34.6) | 21 | (37.5) | 0.9 | 2 | 0.63 |
| Protestant | 70 | (17.7) | 25 | (19.8) | 40 | (18.7) | 5 | (8.9) | 3.5 | 2 | 0.17 |
| Jewish | 20 | (5.1) | 12 | (9.5)a | 7 | (3.3)a | 1 | (1.8) | 7.9 | 2 | 0.02 |
| Muslim | 5 | (1.3) | 2 | (1.6) | 3 | (1.4) | 0 | (0.0) | 0.9 | 2 | 0.65 |
| Pentecostal | 9 | (2.3) | 2 | (1.6) | 5 | (2.3) | 2 | (3.6) | 0.7 | 2 | 0.71 |
| Baptist | 57 | (14.4) | 13 | (10.3) | 34 | (15.9) | 10 | (17.9) | 2.6 | 2 | 0.27 |
| Other | 71 | (17.9) | 19 | (15.1) | 37 | (17.3) | 13 | (26.8) | 3.7 | 2 | 0.15 |
| None | 19 | (4.8) | 3 | (2.4) | 14 | (6.5) | 2 | (3.6) | 3.2 | 2 | 0.20 |
| Site, n (%) | 52.9 | 12 | <0.001 | ||||||||
| Yale | 81 | (20.5) | 24 | (19.1) | 46 | (21.5) | 11 | (19.6) | 0.3 | 2 | 0.87 |
| VACT | 25 | (6.3) | 12 | (9.5) | 12 | (5.6) | 1 | (1.8) | 4.3 | 2 | 0.12 |
| MSK | 30 | (7.6) | 11 | (8.7) | 15 | (7.0) | 4 | (7.1) | 0.4 | 2 | 0.83 |
| Simmons | 32 | (8.1) | 10 | (7.9) | 15 | (7.0) | 7 | (12.5) | 1.8 | 2 | 0.40 |
| Parkland | 152 | (38.4) | 27 | (21.4)ac | 94 | (43.9)a | 31 | (55.4)c | 24.7 | 2 | <0.001 |
| DFCI/MGH | 9 | (2.3) | 1 | (0.8) | 7 | (3.3) | 1 | (1.8) | 2.2 | 2 | 0.33 |
| NHOH | 67 | (16.9) | 41 | (32.5)ac | 25 | (11.7)a | 1 | (1.8)c | 36.0 | 2 | <0.001 |
| Diagnosis, n (%) | 12.5 | 10 | 0.25 | ||||||||
| Lung cancer | 85 | (21.5) | 28 | (22.2) | 50 | (23.4) | 7 | (12.5) | 3.5 | 2 | 0.18 |
| Colorectal cancer | 57 | (14.8) | 18 | (14.3) | 32 | (15.0) | 7 | (12.5) | 0.3 | 2 | 0.87 |
| Breast cancer | 42 | (10.6) | 8 | (6.4) | 26 | (12.2) | 8 | (14.3) | 3.4 | 2 | 0.19 |
| Pancreatic cancer | 37 | (9.6) | 16 | (12.7) | 19 | (8.9) | 2 | (3.6) | 4.4 | 2 | 0.11 |
| Other GI cancer | 54 | (13.6) | 16 | (12.7) | 28 | (13.1) | 10 | (17.9) | 0.7 | 2 | 0.70 |
| Other cancers | 121 | (30.6) | 40 | (31.8) | 59 | (27.6) | 22 | (39.3) | 3.0 | 2 | 0.22 |
CC -Charlson Comorbidity; VACT -Veteran's Association of Connecticut; MSK -Memorial Sloan Kettering; DFCI -Dana Farber Cancer Institute; MGH -Massachusetts General Hospital; NHOH -New Hampshire Oncology-Hematology; GI -Gastrointestinal.
All outcomes for continuous variables were calculated using the t-test.
All dichotomous comparisons were calculated using the Fisher Chi square test. If expected cell count was less than 5, the Cochran-Mantel-Haenszel General Association Statistics were used.
indicates a significant (p < .0167) difference between older aged and middle-aged patients.
indicates a significant (p < .0167) difference between middle-aged and younger aged patients.
indicates a significant (p < .0167) difference between older aged and younger aged patients.